{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:52:09Z","timestamp":1777863129976,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejpn.2014.12.010","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T15:51:00Z","timestamp":1419090660000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacological interaction between valproic acid and carbapenem: What about levels in pediatrics?"],"prefix":"10.1016","volume":"19","author":[{"given":"M\u00aa Concepci\u00f3n","family":"Miranda Herrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s J.","family":"Alcaraz Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Escudero Vilaplana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Nicole","family":"Fern\u00e1ndez Lafever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Mart\u00ednez","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estibaliz","family":"Barredo Valderrama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"V\u00e1zquez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpn.2014.12.010_bib1","first-page":"175","article-title":"Epileptic syndromes: differential treatment in infants, children, and adolescents","volume":"111","author":"Foulon","year":"2011","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.ejpn.2014.12.010_bib2","unstructured":"Technical valproic acid."},{"key":"10.1016\/j.ejpn.2014.12.010_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study","volume":"49","author":"Haroutiunian","year":"2009","journal-title":"J Clin Pharmacol"},{"issue":"Suppl.6","key":"10.1016\/j.ejpn.2014.12.010_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1528-1167.2008.01756.x","article-title":"Perspective on interactions between antiepileptic drugs (AEDs) and antimicrobial agents","volume":"49","author":"Desai","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.12.010_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ejpn.2014.12.010_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","article-title":"Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations","volume":"31","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ejpn.2014.12.010_bib7","first-page":"43","article-title":"Meropenem decreases valproate plasmatic concentrations","volume":"137","author":"Fern\u00e1ndez","year":"2011","journal-title":"Med Clin (Barc)"},{"issue":"13","key":"10.1016\/j.ejpn.2014.12.010_bib8","first-page":"623","article-title":"Valproate-meropenem interaction as an example of information shortcomings in relevant drug interaction","volume":"135","author":"Ib\u00e1\u00f1ez","year":"2010","journal-title":"Med Clin (Barc)"},{"issue":"2\u20134","key":"10.1016\/j.ejpn.2014.12.010_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/DMDI.2009.24.2-4.153","article-title":"Valproic acid-carbapenem interaction: report of six cases and a review of the literature","volume":"24","author":"Tobin","year":"2009","journal-title":"Drug Metabol Drug Interact"},{"issue":"4","key":"10.1016\/j.ejpn.2014.12.010_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.ejpn.2014.12.010_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1157\/13083841","article-title":"Interacci\u00f3n farmacocin\u00e9tica entre \u00e1cido valproico y meropenem","volume":"64","author":"Sala","year":"2006","journal-title":"An Pediatr"},{"issue":"2","key":"10.1016\/j.ejpn.2014.12.010_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.33588\/rn.4602.2007567","article-title":"Meropenem y \u00e1cido valproico: una asociaci\u00f3n peligrosa","volume":"46","author":"Eimil","year":"2008","journal-title":"Rev Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2014.12.010_bib13","first-page":"258","article-title":"Interacci\u00f3n farmacocin\u00e9tica entre \u00e1cido valproico y antibi\u00f3ticos carbapen\u00e9micos: descripci\u00f3n de tres casos","volume":"27","author":"Llinares","year":"2003","journal-title":"Farm Hosp"},{"issue":"2","key":"10.1016\/j.ejpn.2014.12.010_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anpedi.2008.08.009","article-title":"Meropenem y \u00e1cido valproico: una interacci\u00f3n a recordar","volume":"70","author":"San Antonio","year":"2009","journal-title":"An Pediatr (Barc)"},{"issue":"7","key":"10.1016\/j.ejpn.2014.12.010_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","article-title":"Interaction between valproate and meropenem: a retrospective study","volume":"41","author":"Spriet","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.ejpn.2014.12.010_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","article-title":"Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin","volume":"42","author":"De Turck","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ejpn.2014.12.010_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2710.2007.00814.x","article-title":"Adverse events caused by drug interactions involving glucuronoconjugates of zidovudine, valproic acid and lamotrigine, and analysis of how such potential events are discussed in package inserts of Japan, UK and USA","volume":"32","author":"Hirata-Koizumi","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.ejpn.2014.12.010_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2146\/ajhp050512","article-title":"Meropenem\u2013valproic acid interaction in patients with cefepime-associated status epilepticus","volume":"64","author":"Spriet","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.ejpn.2014.12.010_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2710.2006.00743.x","article-title":"Epileptic seizures caused by low valproic acid levels from an interaction with meropenem","volume":"31","author":"Fudio","year":"2006","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.ejpn.2014.12.010_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":"Acute seizures due to a probable interaction between valproic acid and meropenem","volume":"39","author":"Coves","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ejpn.2014.12.010_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","article-title":"Meropenem decreases serum level of valproic acid","volume":"31","author":"Nacarkucuk","year":"2004","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2014.12.010_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0025-7753(04)74403-6","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"123","author":"P\u00e9rez Plasencia","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ejpn.2014.12.010_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":"Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipemen\/betamipron","volume":"39","author":"Nagai","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejpn.2014.12.010_bib24","article-title":"Analysis of the valproic acid-meropenem interaction in hospitalised patients","author":"V\u00e9lez-D\u00edaz-Pallar\u00e9s","year":"2011","journal-title":"Neurologia"},{"key":"10.1016\/j.ejpn.2014.12.010_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2013.03.022","article-title":"Seizures from valproate\u2013carbapenem interaction","volume":"49","author":"Taha","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2014.12.010_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","article-title":"Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases","volume":"34","author":"Park","year":"2012","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.ejpn.2014.12.010_bib27","first-page":"293","article-title":"Drug interaction between valproic acid and meropenem: a case report","volume":"95","author":"Suntimaleeworakul","year":"2012","journal-title":"J Med Assoc Thai"},{"issue":"12","key":"10.1016\/j.ejpn.2014.12.010_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.ejpn.2014.12.010_bib29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1013046229699","article-title":"Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits","volume":"18","author":"Yokogawa","year":"2001","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.ejpn.2014.12.010_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00498254.2011.596582","article-title":"Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid","volume":"41","author":"Suzuki","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejpn.2014.12.010_bib31","unstructured":"Technical meropenem."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814002116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814002116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:01:20Z","timestamp":1747242080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1090379814002116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.12.010","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interaction between valproic acid and carbapenem: What about levels in pediatrics?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}